From: Investigating zero transmission of HIV in the MSM population: a UK modelling case study
Key parameter | Scenario input valuesa | ||||||
---|---|---|---|---|---|---|---|
Base case | Combination prevention | Combination prevention, 98% TasP | Combination prevention, 99% TasP | Aspirational combination prevention | NHS-commissioned PrEP base caseb | NHS-commissioned PrEP combination prevention | |
Rate of PrEP uptake | 0.08%c | 0.25% | 0.25% | 0.25% | 0.45% | 0.08%c | 0.25% |
Proportion of MSMLWH diagnosed within three months of transmission | 26.00% [4] | 40.00% | 40.00% | 40.00% | 40.00% | 26.00% [4] | 40.00% |
Annual probability of having an HIV test | 22.35% [4] | 40.00% | 40.00% | 40.00% | 50.00% | 22.35% [4] | 40.00% |
Probability of starting treatment within six months of diagnosis | 95.17% [31] | 98.00% | 98.00% | 98.00% | 98.00% | 95.17% [31] | 98.00% |
Probability of starting treatment within three months of diagnosis | 78.00% [6] | 90.00% | 90.00% | 90.00% | 95.00% | 78.00% [6] | 90.00% |
TasP | 97% [16] | 97% | 98% | 99% | 99% | 97% [16] | 99% |